International Journal of Pharmaceutical Compounding

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

Lidocaine 2%, Metronidazole 2%, Misoprostol 0.0024% Topical Ointment

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2015 - Volume 19, Number 5
View All Articles in Issue

Page(s): 406

Lidocaine 2%, Metronidazole 2%, Misoprostol 0.0024% Topical Ointment Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Lidocaine 2%, Metronidazole 2%, Misoprostol 0.0024% Topical Ointment. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, formulation, lidocaine, metronidazole, misoprostol, wounds, wound healing, decubitus ulcers, bedsores

Related Categories: DERMATOLOGY, FORMULATIONS, WOUND CARE, DOSAGE FORMS/DRUG CARRIERS, INFECTIOUS DISEASE

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Options in Wound Care Kincaid Michele R	Mar/Apr 2002 Pg. 92-95
Current Topical Treatments in Wound Healing - Part 1 Helmke Christopher D	Jul/Aug 2004 Pg. 269-274
Lidocaine 2%, Metronidazole 2%, Misoprostol 0.0024% Topical Ointment Allen Loyd V Jr	Sep/Oct 2015 Pg. 406
A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin Riepl Mike	Mar/Apr 2022 Pg. 94-98
A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing Riepl Mike	Nov/Dec 2022 Pg. 480-488
Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 2 Riepl Mike	Jul/Aug 2020 Pg. 278-281
Case Report: Wound Care of a Diabetic Foot Ulcer Wynn Tom	Jul/Aug 2004 Pg. 265-267
Misoprostol 0.0024%, Metronidazole 2%, and Pentoxifyline 5% Decubitus Ulcer Cream Allen Loyd V Jr	May/Jun 2002 Pg. 204
Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 1 Riepl Mike	May/Jun 2020 Pg. 182-186
Lidocaine HCl 2%, Misoprostol 0.0024% and Phenytoin 2% Topical Wound Powder Allen Loyd V Jr	Jul/Aug 2004 Pg. 298
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Compounding Pearls -- Wound Care: Burn Healing, Part 2 Riepl Mike	Jul/Aug 2020 Pg. 282-285
Metronidazole 10%, Nifedipine 0.5%, Lidocaine 1.5%, and Diclofenac 3% Ointment Allen Loyd V Jr	Sep/Oct 2022 Pg. 430
Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications Agbi Kelechi E, Carvalho Maria, Phan Ha, Tuma Cristiane	Jan/Feb 2017 Pg. 22-27
Gentamicin Sulfate 0.2%, Misoprostol 0.0024%, and Phenytoin 5% Topical Gel Allen Loyd V Jr	Nov/Dec 2004 Pg. 472
Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 2 Riepl Mike	Jul/Aug 2021 Pg. 282-287
Erratum: Allen LV Jr. Lidocaine hydrochloride 2%, misoprostol 0.0024%, and phenytoin 2% topical wound powder. IJPC 2004; 8(4): 298 Allen Loyd V Jr	Mar/Apr 2006 Pg. 82
Lidocaine HCl 2%, Misoprostol 0.003% and Phenytoin 2.5% Topical Gel for Decubitus Ulcers Allen Loyd V Jr	Jul/Aug 2000 Pg. 301
Compounding Pearls -- Wound Care: Base Selection Riepl Mike	Mar/Apr 2020 Pg. 98-102
Compounding Pearls -- Wound Care: Burn Healing, Part 1 Riepl Mike	May/Jun 2020 Pg. 188-193
Return to Top